These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28497628)

  • 1. Successful patch testing of a patient receiving anti-interleukin-17 therapy with secukinumab: a case report.
    Hamann D; Zirwas M
    Contact Dermatitis; 2017 Jun; 76(6):378-379. PubMed ID: 28497628
    [No Abstract]   [Full Text] [Related]  

  • 2. Isothiazolinones in paint as a cause of airborne contact dermatitis in a patient with psoriasis receiving anti-interleukin-17 therapy.
    Martinez-Mera C; González MA; Hospital M; Turrión-Merino L
    Contact Dermatitis; 2019 May; 80(5):328-329. PubMed ID: 30578553
    [No Abstract]   [Full Text] [Related]  

  • 3. Recall dermatitis at patch test sites in an atopic dermatitis patient treated with dupilumab.
    Collantes-Rodríguez C; Jiménez-Gallo D; Ossorio-García L; Villegas-Romero I; Linares-Barrios M
    Contact Dermatitis; 2019 Jan; 80(1):69-70. PubMed ID: 30334260
    [No Abstract]   [Full Text] [Related]  

  • 4. Sorbitan sesquioleate.
    Castanedo-Tardan MP; Jacob SE
    Dermatitis; 2008; 19(4):E22-3. PubMed ID: 18674450
    [No Abstract]   [Full Text] [Related]  

  • 5. Patch testing a patient with allergic contact hand dermatitis who is taking infliximab.
    Rosmarin D; Bush M; Scheinman PL
    J Am Acad Dermatol; 2008 Jul; 59(1):145-7. PubMed ID: 18468722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two cases of contact dermatitis caused by calcipotriol cream.
    Garcia-Bravo B; Camacho F
    Am J Contact Dermat; 1996 Jun; 7(2):118-9. PubMed ID: 8796754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of "contact allergy to corticosteroid.".
    Green C; Kenicer KJ
    Contact Dermatitis; 1993 Jan; 28(1):39-40. PubMed ID: 8428446
    [No Abstract]   [Full Text] [Related]  

  • 8. Allergic contact dermatitis to sorbitan sesquioleate in Adaptic wound dressing.
    de Waard-van der Spek FB; Devillers AC; Oranje AP
    Contact Dermatitis; 2007 Jul; 57(1):54-6. PubMed ID: 17577361
    [No Abstract]   [Full Text] [Related]  

  • 9. Allergic contact dermatitis to propylene glycol in calcipotriene ointment.
    Fisher DA
    Cutis; 1997 Jul; 60(1):43-4. PubMed ID: 9252735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, exhibits minimal immunogenicity in patients with moderate-to-severe plaque psoriasis.
    Reich K; Blauvelt A; Armstrong A; Langley RG; Fox T; Huang J; Papavassilis C; Liang E; Lloyd P; Bruin G
    Br J Dermatol; 2017 Mar; 176(3):752-758. PubMed ID: 27518376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Generalized Pustular Psoriasis Treated With the IL-17A Antibody Secukinumab.
    Böhner A; Roenneberg S; Eyerich K; Eberlein B; Biedermann T
    JAMA Dermatol; 2016 Apr; 152(4):482-4. PubMed ID: 26650014
    [No Abstract]   [Full Text] [Related]  

  • 12. First case of secukinumab successful therapy in a very elderly psoriatic patient.
    Ricceri F; Pescitelli L; Lazzeri L; Di Cesare A; Prignano F
    Dermatol Ther; 2018 Sep; 31(5):e12668. PubMed ID: 30209856
    [No Abstract]   [Full Text] [Related]  

  • 13. Allergic contact dermatitis to sorbitan sesquioleate in children.
    Castanedo-Tardan MP; Jacob SE
    Contact Dermatitis; 2008 Mar; 58(3):171-2. PubMed ID: 18279159
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of effect of ustekinumab in treatment of allergic contact dermatitis.
    Bangsgaard N; Zachariae C; Menné T; Skov L
    Contact Dermatitis; 2011 Oct; 65(4):227-30. PubMed ID: 21718332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergic contact dermatitis caused by sorbitan sesquioleate imitating severe glove dermatitis in a patient with filaggrin mutation.
    Hald M; Menné T; Johansen JD; Zachariae C
    Contact Dermatitis; 2013 Nov; 69(5):313-5. PubMed ID: 24117742
    [No Abstract]   [Full Text] [Related]  

  • 16. Erythrodermic psoriasis and secukinumab: Our clinical experience.
    Mateu-Puchades A; Santos-Alarcón S; Martorell-Calatayud A; Pujol-Marco C; Sánchez-Carazo JL
    Dermatol Ther; 2018 Jul; 31(4):e12607. PubMed ID: 29663615
    [No Abstract]   [Full Text] [Related]  

  • 17. Secukinumab in multi-failure psoriatic patients: the last hope?
    Magnano M; Loi C; Patrizi A; Sgubbi P; Balestri R; Rech G; Tasin L; Girardelli CR; Conti A; Odorici G; Campanati A; Offidani AM; Bardazzi F
    J Dermatolog Treat; 2018 Sep; 29(6):583-585. PubMed ID: 29334270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sorbitan sesquioleate: an emerging contact allergen.
    Asarch A; Scheinman PL
    Dermatitis; 2008; 19(6):339-41. PubMed ID: 19134439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secukinumab (AIN-457) for the treatment of Psoriasis.
    Jaleel T; Elmets C; Weinkle A; Kassira S; Elewski B
    Expert Rev Clin Pharmacol; 2016; 9(2):187-202. PubMed ID: 26647300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secukinumab for psoriasis in a patient with hepatitis B.
    Feaster B; Cline A; Feldman SR
    Dermatol Online J; 2018 Sep; 24(9):. PubMed ID: 30677838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.